Viswanadhan Krishnan
SEC CIK 1999913 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | Chief Corp Dev, Strategy | 13.2K | — | $185.0K | 4 | 2026-03-05 | 2026-04-02 |
Most active insiders at AGIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Goff Brian | CEO, Dir | — | $1.69M |
| 2 | Gheuens Sarah | Chief Medical Off | — | $1.63M |
| 3 | Jones Cecilia | CFO | — | $468.5K |
| 4 | Milanova Tsveta | Chief Commercial Off | — | $353.3K |
| 5 | Burns James William | CLO | — | $344.4K |
| 6 | Washburn Theodore James Jr. | Principal Accounting Off | — | $216.6K |
| 7 | Viswanadhan Krishnan | Chief Corp Dev, Strategy | — | $185.0K |
| 8 | Scadden David | Dir | — | $25.0K |
| 9 | Owen Adams Catherine | Dir | — | — |
| 10 | Ballal Rahul D. | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-06 16:05 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Viswanadhan Krishnan | Chief Corp Dev, Strategy | M - OptEx | $0.00 | +8,100 | 13.2K | +158% | $0 |
| DT | 2026-04-06 16:05 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Viswanadhan Krishnan | Chief Corp Dev, Strategy | S - Sale+OE | $34.71 | -2,959 | 10.3K | -22% | -$102.7K |
| D | 2026-03-09 | 2026-03-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Viswanadhan Krishnan | Chief Corp Dev, Strategy | S - Sale+OE | $27.80 | -2,959 | 5,141 | -37% | -$82.3K |
| D | 2026-03-09 | 2026-03-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | Viswanadhan Krishnan | Chief Corp Dev, Strategy | M - OptEx | $0.00 | +8,100 | 8,100 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations